Structure-based inhibition of chemokine signaling in the inflamed pancreas
Structure-based inhibition of chemokine signaling in the inflamed pancreas
批准号:
10656002
负责人:
Michael B Dwinell
金额:
$66.27万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-20 至 2026-12-31
关键词:
Animal ModelBindingBiological AssayBiologyCell Migration Inhibition functionCell modelCell physiologyCellsChemicalsChemotaxisChronicDataDesmoplasticDevelopmentDiseaseDisease ProgressionDuctal Epithelial CellElementsEpithelial CellsFibrosisFunctional disorderG-Protein-Coupled ReceptorsGPR2 geneGoalsHealthHot SpotImmuneImmune responseImmunotherapyInfiltrationInflammationInflammatory ResponseKineticsKnockout MiceKnowledgeLigandsLinkMalignant - descriptorMalignant NeoplasmsMapsMeasuresMethodsModelingMolecularMucositisMucous MembraneNeoplasmsOrganPancreasPancreatic Ductal AdenocarcinomaPancreatic ductPancreatitisPatientsPharmacologyPhysiologicalPlayProtein SecretionPublic HealthPublishingRegulatory T-LymphocyteResearchRisk FactorsRoleSignal TransductionSiteStructural ModelsStructureT cell infiltrationTestingTherapeuticTissuesTumor PromotionWorkcell motilitychemokinechemokine receptorchronic pancreatitisdesigndrug discoveryeffector T cellhigh throughput screeningimprovedin vitro Modelin vivoinhibitormolecular modelingmouse modeloverexpressionpancreas developmentpharmacologicpremalignantprogramsreceptorrecruitresponsescreeningsmall moleculesmall molecule inhibitortherapeutic targettraffickingtumortumor growthtyrosine O-sulfate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Modified Project Summary/Abstract Section
The goal of this project is to establish the role of CCL28 in chronic pancreatitis and use structure-based drug discovery methods to identify small molecule inhibitors of this secreted protein. CCL28 is a mucosal chemokine that promotes tumor growth in a variety of organs by recruiting regulatory T cells (Tregs) that express the G protein-coupled receptor CCR10. Based on our published and preliminary results, we postulate that secretion of the chemokine CCL28 by pancreatic ductal epithelial cells also drives chronic inflammation that progresses to malignant disease. We hypothesize that inhibition of CCL28 activity will alter the pancreatic mucosal microenvironment in a manner that reduces pre-malignant inflammation and enhances the activity of existing chemotherapeutics and immunotherapies. To achieve this objective, we propose three conceptually linked but experimentally independent specific aims. First, we will test our mechanistic hypothesis in animal models of chronic pancreatitis, to demonstrate experimentally that CCL28 activity through CCR10 plays a key role in the fibroinflammatory response in vivo and develop an in vitro model that can be used to screen promising inhibitors (aim 1). Key elements of CCL28 recognition by its G protein-coupled receptor CCR10 will be mapped in detail using NMR and molecular modeling, and we will define the complete intracellular signaling profile of this chemokine receptor using state-of-the-art assay platforms for receptor pharmacology (aim 2). Using the solved NMR structure of CCL28 and knowledge of its sulfotyrosine binding pocket, we will employ a structure-based strategy developed in the Volkman lab that enables the discovery of small molecules that bind a specific chemokine target and inhibit cell migration (aim 3). Collectively, the proposed studies will provide fundamental advances in our understanding of (1) Treg function and pathophysiology in the pancreas, (2) the structural basis for ligand-receptor selectivity and GPCR pharmacology in a largely unexamined chemokine signaling axis, and (3) the druggability of a mucosal chemokine at the tumor-promoting interface of chronic inflammation and neoplasia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biased chemokine receptor signaling in cancer progression
-
批准号:10077789
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2019
-
负责人:Michael B Dwinell
-
依托单位:
Biased chemokine receptor signaling in cancer progression
-
批准号:10541844
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2019
-
负责人:Michael B Dwinell
-
依托单位:
Biased chemokine receptor signaling in cancer progression
-
批准号:10321201
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2019
-
负责人:Michael B Dwinell
-
依托单位:
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
-
批准号:8696182
-
项目类别:
-
资助金额:$52.62万
-
财政年份:2014
-
负责人:Michael B Dwinell
-
依托单位:
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
-
批准号:9281690
-
项目类别:
-
资助金额:$51.58万
-
财政年份:2014
-
负责人:Michael B Dwinell
-
依托单位:
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
-
批准号:8883430
-
项目类别:
-
资助金额:$52.25万
-
财政年份:2014
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:8474410
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:8738644
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:9346649
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:9126555
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
Epithelial CXCR4 in a Mucosal Communication Network
-
批准号:8069072
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2010
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7850314
-
项目类别:
-
资助金额:$1.35万
-
财政年份:2009
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7580914
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:6920569
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7217916
-
项目类别:
-
资助金额:$25.15万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7385964
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7064223
-
项目类别:
-
资助金额:$27.81万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
Chemokines in host defense to Campylobacter jejuni
-
批准号:6803523
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:Michael B Dwinell
-
依托单位:
Chemokines in host defense to Campylobacter jejuni
-
批准号:6675486
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:Michael B Dwinell
-
依托单位:
CHEMOKINE RECEPTOR EXPRESSION ON INTESTINAL EPITHELIUM
-
批准号:6462951
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2000
-
负责人:Michael B Dwinell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: